TARS earnings: a positive outcome, +13.9%

On March 31, 2021, Tarsus Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +13.9% in the window around the event. It had already run -20.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.